Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Home
ETF
EDSA
EDSA
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
EDSA News
Box Inc Q4 Earnings Exceed Expectations
6d ago
Benzinga
Axon Reports Q4 Revenue and Earnings Beat Estimates
Feb 25 2026
Benzinga
Edesa Biotech's Drug Significantly Reduces Mortality Rates
Feb 24 2026
stocktwits
Edesa Biotech Reports Positive Clinical Data
Feb 24 2026
Newsfilter
EDESA BIOTECH INC - PARIDIPRUBART Demonstrates 30% Decrease in Pneumonia Mortality Rates
Feb 24 2026
moomoo
EDESA BIOTECH INC - PARIDIPRUBART LOWERS MORTALITY RATE TO 15% AMONG NON-IMV PATIENTS
Feb 24 2026
moomoo
Edesa Biotech Reports $2.2 Million Net Loss for Q1
Feb 13 2026
seekingalpha
EDESA BIOTECH REPORTS Q1 OPERATING EXPENSES OF USD 2.3 MILLION
Feb 13 2026
moomoo
Edesa Biotech Reports GAAP EPS of -$1.27, Exceeding Estimates by $0.51
Dec 14 2025
SeekingAlpha
Edesa Biotech Reveals Schedule for Upcoming Conferences
Oct 31 2025
Newsfilter
Edesa Biotech Announces Encouraging Phase 3 Outcomes for Paridiprubart in ARDS
Oct 28 2025
NASDAQ.COM
Edesa Biotech Posts Narrower Loss in Q3
Aug 08 2025
NASDAQ.COM
HC Wainwright & Co. Assumes Edesa Biotech at Buy, Announces Price Target of $5
Jun 27 2025
Benzinga
Edesa Biotech to Participate in Bloom Burton Healthcare Investor Conference
Apr 28 2025
Newsfilter
Edesa Biotech Announces Chief Financial Officer Transition
Apr 04 2025
Newsfilter
Edesa Biotech says Peter Weiler to succeed Stephen Lemieux as CFO
Apr 04 2025
Business Insider
Show More News
